Research and Markets: Dry Eye Partnering 2007-2013 - Comprehensive access to over 30 actual dry eye deals entered into by the world's biopharma companies since 2007

Tue May 7, 2013 3:35pm EDT

* Reuters is not responsible for the content in this press release.

Research and Markets: Dry Eye Partnering 2007-2013 - Comprehensive access to over 30 actual dry eye deals entered into by the world's biopharma companies since 2007

Research and Markets (http://www.researchandmarkets.com/research/frjllv/dry_eye) has announced the addition of the "Dry Eye Partnering 2007-2013" report to their offering.

Dry Eye Partnering 2007-2013 report provides understanding and access to the dry eye partnering deals and agreements entered into by the worlds leading healthcare companies.

- Trends in dry eye partnering deals

- Top dry eye deals by value

- Deals listed by company A-Z, industry sector, stage of development, technology type

Dry Eye Partnering 2007-2013 provides understanding and access to the dry eye partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of dry eye partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dry eye technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

Benefits

- In-depth understanding of dry eye deal trends since 2007

- Access to summary headline, upfront, milestone and royalty data

- Comprehensive access to over 30 actual dry eye deals entered into by the world's biopharma companies since 2007

- Insight into key deal terms included in contracts, where disclosed

- Understand the key deal terms companies have agreed in deals

- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

For more information visit http://www.researchandmarkets.com/research/frjllv/dry_eye

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.